Home » Topics » Regulatory » Patents

Patents
RSS

Protein farnesyltransferase inhibitors described by Warner-Lambert

July 26, 1996

Humanized CD38 antibodies for cancer/autoimmune disease treatment

July 26, 1996

Biogal describes cyclosporin emulsions

July 26, 1996

Rapamycin esters from American Home Products

July 26, 1996

Immunoregulatory peptides with special binding properties

July 26, 1996

HSV proteins as immune resonse regulators

July 26, 1996

Erythropoietin claimed as chronic inflammation treatment

July 26, 1996

Matrix metalloproteinase inhibitors described by British Biotech

July 26, 1996

Monoclonal antibody fragments as immunosuppressants

July 26, 1996

COX-2 inhibitors described to treat inflammation

July 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 18, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 18, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...